Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
Patient Benefit-Risk Preferences for Targeted Agents in the Treatment of Renal Cell CarcinomaMohamed, Ateesha F. ; Hauber, A. Brett ; Neary, Maureen P.PharmacoEconomics, 2011-11, Vol.29 (11), p.977-988 [Periódico revisado por pares]Cham: Springer International PublishingTexto completo disponível |
|
2 |
Material Type: Artigo
|
Development Safety Update Reports and Proposals for Effective and Efficient Risk CommunicationUrushihara, Hisashi ; Kawakami, KojiDrug safety, 2010-05, Vol.33 (5), p.341-352 [Periódico revisado por pares]Cham: Springer International PublishingTexto completo disponível |
|
3 |
Material Type: Artigo
|
Comment on: “Desideratum for Evidence-Based Epidemiology”Hennessy, Sean ; Leonard, Charles E.Drug safety, 2015, Vol.38 (1), p.101-103 [Periódico revisado por pares]Cham: Springer International PublishingTexto completo disponível |
|
4 |
Material Type: Artigo
|
Benefit-Risk Assessment of Becaplermin in the Treatment of Diabetic Foot UlcersPapanas, DrNikolaos ; Maltezos, EfstratiosDrug safety, 2010-06, Vol.33 (6), p.455-461 [Periódico revisado por pares]Cham: Springer International PublishingTexto completo disponível |
|
5 |
Material Type: Artigo
|
Congenital Long QT Syndromes: Prevalence, Pathophysiology and ManagementBarsheshet, Alon ; Dotsenko, Olena ; Goldenberg, IlanPaediatric drugs, 2014-12, Vol.16 (6), p.447-456 [Periódico revisado por pares]Cham: Springer International PublishingTexto completo disponível |
|
6 |
Material Type: Artigo
|
Gadoteridol/iohexol: Synovitis: case reportReactions weekly, 2022, Vol.1888 (1), p.180-180Cham: Springer International PublishingTexto completo disponível |
|
7 |
Material Type: Artigo
|
Bevacizumab/doxorubicin: Myelosuppression and hypertension: 3 case reportsReactions weekly, 2022, Vol.1888 (1), p.103-103Cham: Springer International PublishingTexto completo disponível |
|
8 |
Material Type: Artigo
|
Inotuzumab-ozogamicin: Liver toxicity: case reportReactions weekly, 2022, Vol.1889 (1), p.178-178Cham: Springer International PublishingTexto completo disponível |
|
9 |
Material Type: Artigo
|
Camrelizumab/rivoceranib: Hypertension, leucopenia and thrombocytopenia following off-label use: case reportReactions weekly, 2022, Vol.1895 (1), p.111-111Cham: Springer International PublishingTexto completo disponível |
|
10 |
Material Type: Artigo
|
Potassium/sodium chloride/topiramate: Electrolyte abnormalities, renal tubular acidosis and lack of efficacy: case reportReactions weekly, 2022, Vol.1888 (1), p.300-300Cham: Springer International PublishingTexto completo disponível |